移至主內容
Taiwan Novartis Pro | 台灣諾華醫學資訊平台
登入
What are you looking for?
All Filters
Therapeutic Area
Therapeutic Area
Date Published
Date published
Navigation
Navigation

Navigation

  • Kymriah® (tisagenlecleucel)
    • Kymriah e-Compass 0_CAR-T 規劃小幫手
    • Kymriah e-Compass 1_What is CAR-T?
    • Kymriah e-Compass 2_健保給付條文
    • Kymriah e-Compass 3_病人辨識 & 轉介流程
    • Kymriah e-Compass 4_白血球分離術
    • Kymriah e-Compass 5_橋接治療
    • Kymriah e-Compass 6_淋巴細胞清除性化療
    • Kymriah e-Compass 7_細胞輸注流程
    • Kymriah e-Compass 8_AE 監測與處置
    • Kymriah e-Compass 9_治療經驗分享
    • Kymriah e-Compass 10_常見問題
  • Scemblix® (asciminib)
    • Scemblix 全精華 FAQ
    • Signaling Change_How would you manage a patient with a suboptimal response on their 2nd TKI
    • Signaling Change_How would you treat a patient who is experiencing intolerance on their 2nd TKI
    • Signaling Change_What are the considerations for switching to a new treatment rather than adjusting dose in CML
  • Jakavi® (ruxolitinib)
    • MAJIC-PV 試驗聚焦 系列一 Jakavi®在PV的最新臨床證據
    • MAJIC-PV 試驗聚焦 系列二 Jakavi®全面且持久的症狀控制
    • MAJIC-PV 試驗聚焦 系列三 Jakavi®達成更高且更持久的血液完全緩解
    • MAJIC-PV 試驗聚焦 系列四 Jakavi®更能改善無事件存活期
    • Ruxolitinib in a broad range of patients 系列1 高風險MF病人
    • Ruxolitinib in a broad range of patients 系列2 較低風險MF病人更能獲得臨床效益
    • Ruxolitinib in a broad range of patients 系列3 別讓貧血影響您使用Jakavi的治療規劃
    • JAKAVI® 能延長存活期且不受貧血影響
  • Jadenu® (deferasirox)
    • 拿鐵無憂 MDS 3合1風味拿鐵 Decaf Latte
    • 拿鐵無憂 MDS 3合1風味拿鐵 Matcha Latte
    • 拿鐵無憂 MDS 3合1風味拿鐵 Salted Caramel
  • Revolade® (eltrombopag olamine)
    • 【SAA發燒議題】SAA年長病患最新治療方案

產品資訊

  • 列印
  • PDF
Image
Scemblix_header
  • 列印
  • PDF

台灣諾華
本網站僅提供醫療專業人員使用

  • 探索網站
  • 實用連結
  • 使用條款
  • 隱私聲明

© 2026 Novartis

This website is only intended for healthcare professionals with prescribing authority.

I am a Healthcare Professional.
I am not a Healthcare Professional.

and agree to the Data Privacy and Term of Use policy of this website

The Novartis portal for UK healthcare professionals (HCPs) and other relevant decision makers* is where you can find promotional information about Novartis products, therapy area materials and professional resources.

*Other relevant decision makers particularly includes those with an NHS role who could influence in any way the administration, consumption, prescription, purchase, recommendation, sale, supply or use of any medicine but who are not health professionals.

Login